Drug test for qualitative analysis of the protein mutation of the epithelial growth factor receptor E746-A750 del - Vietnam Registration 230000316/PCBB-BYT
Access comprehensive regulatory information for Drug test for qualitative analysis of the protein mutation of the epithelial growth factor receptor E746-A750 del in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 230000316/PCBB-BYT and manufactured by Ventana Medical Systems, Inc..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
230000316/PCBB-BYT
000.00.04.G18-230726-0010
anti-EGFR E746-A750 del (SP111) Rabbit Monoclonal Primary Antibody
06521932001
Technical Details
Anti-EGFR E746-A750 del (SP111) Rabbit Monoclonal Primary Antibody (SP111 (anti-EGFR E746-A750 del (SP111)) expressed as membrane and/or cytoplasmic type and can be used to support the determination of the protein variant of the epidermal growth factor receptor, EGFR E746-A750 del. This antibody is used for qualitative staining of formalin-fixed paraffin-embedded tissue sections. The test result must be interpreted by a qualified histopathologist in combination with histological examination, relevant clinical information, and appropriate control material. This antibody is intended for in vitro diagnostic use (IVD).
Dates and Status
Jul 26, 2023